Nortis, a Seattle-area startup based in 2011 that markets “organ-on-a-chip” know-how, has raised $6 million, in keeping with an SEC submitting. The corporate’s microfluidic chips foster the expansion of human cells in ways in which resemble organs, and have been used to create kidney, liver, blood vessel, coronary heart, gut, and tumor fashions for researchers….
